Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06313697
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2024-03-05
Brief Title:
A Study to Evaluate the Safety Immunogenicity and Pharmacokinetics of GR2102 in Healthy Adult
Sponsor:
Organization:
Genrix Shanghai Biopharmaceutical Co Ltd